First Berlin Reiterates Buy Rating for MPH Health Care AG

First Berlin Equity Research GmbH has issued a research update for MPH Health Care AG. Analyst Ellis Acklin has reaffirmed his Buy recommendation, setting a target price of €108. The latest figures for the nine-month period indicate a significant increase in value.

The company's net asset value (NAV) grew by 20% in the first nine months of 2024 and saw a 39% rise year-over-year, reaching €300 million. Concurrently, the net asset value per share (NAVPS) reached €70.10. M1 Kliniken's shares increased by 50%, benefiting from the positive momentum of its burgeoning prejuvination segment.

CR Energy anticipates 2024 results will be more prominent in the latter half of the year, though its holdings in Terrabau and Solartec already generated €9.5 million in profit in the first half of 2024. Despite a challenging property market, M1 has expanded to 63 clinics, aiming for 150-200 by 2029. CRE's clean energy and affordable housing sectors continue to prosper.